Shengkui Qiu
- Cancer Research top 10%
- MicroRNA in disease regulation 4
-
- Circular RNAs in diseases 4
- Extracellular vesicles in disease 3
- RNA modifications and cancer 2
- Ubiquitin and proteasome pathways 2
-
- Pancreatic and Hepatic Oncology Research 2
- Peptidase Inhibition and Analysis 2
-
- Cancer Mechanisms and Therapy 2
- Co-authors
- Jialun LvYiwen XiaBowen LiZekuan XuZhe XuanLi XieTianlu JiangZhongyuan He
- Partner nations
- China
In The Last Decade
Shengkui Qiu
10 papers receiving 414 citations
Hit Papers
Peers
Comparison fields: 5 of 57
- Cancer Research 253
- Molecular Biology 330
- Immunology 79
- Oncology 48
- Pathology and Forensic Medicine 24
Countries citing papers authored by Shengkui Qiu
This map shows the geographic impact of Shengkui Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengkui Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengkui Qiu more than expected).
Fields of papers citing papers by Shengkui Qiu
This network shows the impact of papers produced by Shengkui Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengkui Qiu. The network helps show where Shengkui Qiu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shengkui Qiu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 7 | |
| 6 | 2023 | 24 | |
| 7 | 2023 | 21 | |
| 8 | Gastric cancer-derived exosomal miR-519a-3p promotes liver metastasis by inducing intrahepatic M2-like macrophage-mediated angiogenesisbreakdown → | 2022 | 150 |
| 9 | 2022 | 0 | |
| 10 | 2021 | 44 | |
| 11 | 2021 | 0 | |
| 12 | 2021 | 161 |
About Shengkui Qiu
Shengkui Qiu is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 12 papers that have together received 420 indexed citations. Recurring topics across this work include Circular RNAs in diseases (4 papers), MicroRNA in disease regulation (4 papers), Extracellular vesicles in disease (3 papers), Pancreatic and Hepatic Oncology Research (2 papers), RNA modifications and cancer (2 papers), Cancer Mechanisms and Therapy (2 papers), Peptidase Inhibition and Analysis (2 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Cancer Research (253 citations), Molecular Biology (330 citations) and Immunology (79 citations). Shengkui Qiu has collaborated with scholars based in China. Frequent co-authors include Jialun Lv, Yiwen Xia, Bowen Li, Zekuan Xu, Zhe Xuan, Li Xie, Tianlu Jiang, Zhongyuan He, Lang Fang and Chao Gu. Their work appears in journals such as Oncogene, Small and Molecular Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.